Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein

被引:69
作者
Szanto, Magdolna [1 ]
Brunyanszki, Attila [1 ]
Kiss, Borbala [2 ]
Nagy, Lilla [1 ]
Gergely, Pal [1 ]
Virag, Laszlo [1 ]
Bai, Peter [1 ]
机构
[1] Univ Debrecen, Dept Med Chem, MHSC, H-4032 Debrecen, Hungary
[2] Univ Debrecen, Dept Dermatol, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
关键词
PARP-2; ARTD2; SIRT1; DNA repair; Differentiation; Metabolism; Mitochondria; SELECTIVE PARP-2 INHIBITORS; SMALL-MOLECULE ACTIVATORS; CELLULAR-RESPONSE; MITOCHONDRIAL-FUNCTION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; SIRT1; DAMAGE; BINDING; INJURY;
D O I
10.1007/s00018-012-1003-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribose) polymerase (PARP)-2 is a nuclear enzyme that belongs to the PARP family and PARP-2 is responsible for 5-15 % of total cellular PARP activity. PARP-2 was originally described in connection to DNA repair and in physiological and pathophysiological processes associated with genome maintenance (e.g., centromere and telomere protection, spermiogenesis, thymopoiesis, azoospermia, and tumorigenesis). Recent reports have identified important rearrangements in gene expression upon the knockout of PARP-2. Such rearrangements heavily impact inflammation and metabolism. Metabolic effects are mediated through modifying PPAR gamma and SIRT1 function. Altered gene expression gives rise to a complex phenotype characterized primarily by enhanced mitochondrial activity that results both in beneficial (loss of fat, enhanced insulin sensitivity) and in disadvantageous (pancreatic beta cell hypofunction upon high fat feeding) consequences. Enhanced mitochondrial biogenesis provides protection in oxidative stress-related diseases. Hereby, we review the recent developments in PARP-2 research with special attention to the involvement of PARP-2 in transcriptional and metabolic regulation.
引用
收藏
页码:4079 / 4092
页数:14
相关论文
共 113 条
[61]   Combinatorial control of gene expression by nuclear receptors and coregulators [J].
McKenna, NJ ;
O'Malley, BW .
CELL, 2002, 108 (04) :465-474
[62]   PARP-1 and PARP-2 interact with nucleophosmin/β23 and accumulate in transcriptionally active nucleoli [J].
Meder, VS ;
Boeglin, M ;
de Murcia, G ;
Schreiber, V .
JOURNAL OF CELL SCIENCE, 2005, 118 (01) :211-222
[63]   ZINC-BINDING DOMAIN OF POLY(ADP-RIBOSE)POLYMERASE PARTICIPATES IN THE RECOGNITION OF SINGLE-STRAND BREAKS ON DNA [J].
MENISSIERDEMURCIA, J ;
MOLINETE, M ;
GRADWOHL, G ;
SIMONIN, F ;
DEMURCIA, G .
JOURNAL OF MOLECULAR BIOLOGY, 1989, 210 (01) :229-233
[64]   Poly(ADP-Ribose) Polymerases PARP1 and PARP2 Modulate Topoisomerase II Beta (TOP2B) Function During Chromatin Condensation in Mouse Spermiogenesis [J].
Meyer-Ficca, Mirella L. ;
Lonchar, Julia D. ;
Ihara, Motomasa ;
Meistrich, Marvin L. ;
Austin, Caroline A. ;
Meyer, Ralph G. .
BIOLOGY OF REPRODUCTION, 2011, 84 (05) :900-909
[65]   Sirtuins in mammals: insights into their biological function [J].
Michan, Shaday ;
Sinclair, David .
BIOCHEMICAL JOURNAL, 2007, 404 :1-13
[66]   Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes [J].
Milne, Jill C. ;
Lambert, Philip D. ;
Schenk, Simon ;
Carney, David P. ;
Smith, Jesse J. ;
Gagne, David J. ;
Jin, Lei ;
Boss, Olivier ;
Perni, Robert B. ;
Vu, Chi B. ;
Bemis, Jean E. ;
Xie, Roger ;
Disch, Jeremy S. ;
Ng, Pui Yee ;
Nunes, Joseph J. ;
Lynch, Amy V. ;
Yang, Hongying ;
Galonek, Heidi ;
Israelian, Kristine ;
Choy, Wendy ;
Iffland, Andre ;
Lavu, Siva ;
Medvedik, Oliver ;
Sinclair, David A. ;
Olefsky, Jerrold M. ;
Jirousek, Michael R. ;
Elliott, Peter J. ;
Westphal, Christoph H. .
NATURE, 2007, 450 (7170) :712-716
[67]  
MIWA M, 1984, METHOD ENZYMOL, V106, P495
[68]  
MIWA M, 1984, METHOD ENZYMOL, V106, P441
[69]   PolyADP-ribosylation and cancer [J].
Miwa, Masanao ;
Masutani, Mitsuko .
CANCER SCIENCE, 2007, 98 (10) :1528-1535
[70]   Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage [J].
Moroni, F. ;
Formentini, L. ;
Gerace, E. ;
Camaioni, E. ;
Pellegrini-Giampietro, D. E. ;
Chiarugi, A. ;
Pellicciari, R. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (05) :854-862